TheStreet.com  Jun 22  Comment 
NEW YORK (TheStreet) -- Shares of ZIOPHARM Oncology Inc  were up 0.41% to $12.19 in mid-morning trading Monday, despite getting a rating cut by analysts at BMO Capital earlier this morning. The firm downgraded shares of the biotechnology...
Benzinga  Jun 5  Comment 
Intrexon Corporation ("Intrexon") (NYSE: XON), a leader in synthetic biology, today announced that it has determined the final distribution ratio relating to its previously announced distribution of all of its 17,830,305 shares of ZIOPHARM...
Benzinga  Jun 2  Comment 
ZIOPHARM Oncology, Inc. (Nasdaq: ZIOP), a biopharmaceutical company focused on the development and commercialization of new cancer therapies, today announced that Caesar J. Belbel, Executive Vice President, Chief Legal Officer and Secretary, has...
Motley Fool  Apr 27  Comment 
Ziopharm Oncology shares are heading lower as investors book profits after a big move this year.
TheStreet.com  Apr 20  Comment 
NEW YORK (TheStreet) -- Shares of Ziopharm Oncology  fell 7.68% to $11 in afternoon trading Monday after so-called CAR-T cellular therapies for solid tumors showed mediocre results at a conference on Sunday. Ziopharm is currently working with...
TheStreet.com  Apr 2  Comment 
BOSTON (TheStreet) -- Welcome to the pre-Passover/Easter Biotech Stock Mailbag. May you get your fill of matzoh and Peeps this weekend.  @adamfeuerstein Looks like good news $NWBO — Jeffrey Feldman (@JeffreyFeldman5) March 27, 2015 ...
Motley Fool  Mar 30  Comment 
Merck Serono is teaming up with Intrexon Corp and Ziopharm Oncology, Inc. on CAR-T immunotherapies.
Motley Fool  Mar 25  Comment 
Ziopharm Oncology Inc.'s shares are retreating following a more than doubling since January.
TheStreet.com  Mar 11  Comment 
Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of Jim Cramer, TheStreet, Inc., or any of its contributors.  TheStreet Ratings quantitative algorithm evaluates over 4,300 stocks on...



Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki